Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study

被引：2
|
作者：
Townsend, T. [1 ]
Razanskaite, V. [2 ]
Michail, S. [1 ]
Morgan, J. [1 ]
Davies, M. [1 ]
Storey, D. [1 ]
Watters, C. [3 ]
Penman, D. [3 ]
Swaminathan, M. [4 ]
Sabine, J. [3 ]
Chapman, A. [2 ]
Vyas, A. [2 ]
Reilly, I. [4 ]
Flanagan, P. [3 ]
Bodger, K. [2 ]
Subramanian, S. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Gastroenterol, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Gastroenterol, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Gastroenterol, Upton, England
[4] Countess Chester Hosp, Gastroenterol, Chester, Cheshire, England
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.710
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P586
引用
收藏
页码：S407 / S408
页数：2
相关论文
共 50 条
  • [31] Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients
    Eroglu, Z.
    Yilmaz, V.
    Er, R. E.
    Soykan, I.
    Toruner, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1182 - I1182
  • [32] Ustekinumab efficacy and safety in Crohn's disease patients refractory to conventional and anti-TNF therapy: a multicenter retrospective experience.
    Wils, P.
    Bouhnik, Y.
    Flourie, B.
    Brixi, H.
    Cosnes, J.
    Allez, M.
    Duclos, B.
    Michetti, P.
    Grimaud, J. -C.
    Bommelaer, G.
    Amiot, A.
    Fumery, M.
    Filippi, J.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S37 - S39
  • [33] LONG-TERM CLINICAL EFFICACY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE: A MULTI-CENTRE BELGIAN COHORT STUDY
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Noman, Maja
    Van Kemseke, Catherine
    Macken, Elisabeth
    De Vos, Martine
    Van Moerkercke, Wouter
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dutre, Joris
    Humblet, Evelien
    Staessen, Dirk
    Peeters, Harald
    Van Hootegem, Philippe
    Louis, Edouard
    Franchimont, Denis
    Baert, Filip J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2019, 156 (06) : S882 - S883
  • [34] Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn's Disease After Failure of Anti-TNF Agents: Real-World Evidence
    Alamer, A.
    Al Lehaibi, L.
    Alomar, M.
    Aldhuwayan, F.
    Alshouish, S.
    Al-Ali, A.
    Almudhry, Z.
    Almulhim, A.
    Althagafi, A.
    Aldosari, S.
    Alameel, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1297 - I1297
  • [35] Long-term clinical efficacy of ustekinumab in refractory Crohn's disease : a multi-centre Belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S44 - S45
  • [36] The Use of Combination Vedolizumab and Ustekinumab in Crohn's Disease: A Retrospective Cohort Study
    Glassner, Kerri
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S355 - S355
  • [37] Short term effectiveness of ustekinumab versus vedolizumab in Crohn's disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis
    Alamer, Ahmad
    Al Lehaibi, Lina H.
    Alomar, Mukhtar
    Aldhuwayan, Fahad
    Alshouish, Saleh
    Al-Ali, Anfal Y.
    Almudhry, Zakia
    Almulhim, Abdulaziz
    Althagafi, Abdulhamid
    Aldosari, Saad
    AlAmeel, Turki
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2024, 30 (05): : 324 - +
  • [38] Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
    Jose Garcia, Maria
    Rivero, Montserrat
    Fernandez-Clotet, Agnes
    de Francisco, Ruth
    Sicilia, Beatriz
    Mesonero, Francisco
    Luisa de Castro, Maria
    Jose Casanova, Maria
    Bertoletti, Federico
    Javier Garcia-Alonso, Francisco
    Lopez-Garcia, Alicia
    Vicente, Raquel
    Calvet, Xavier
    Barreiro-de Acosta, Manuel
    Ferrer Rosique, Juan
    Varela Trastoy, Pilar
    Nunez, Alejandro
    Ricart, Elena
    Riestra, Sabino
    Arias Garcia, Lara
    Rodriguez, Maria
    Arranz, Laura
    Pajares, Ramon
    Mena, Raquel
    Calafat, Margalida
    Camo, Patricia
    Bermejo, Fernando
    Ponferrada, Angel
    Eva Madrigal, Rosa
    Llao, Jordina
    Sese, Eva
    Sanchez, Eugenia
    Pineda Marino, Juan Ramon
    Gonzalez Munoza, Carlos
    Carbajo Lopez, Ana Yaiza
    Belen Julian, Ana
    Villoria Ferrer, Albert
    Baston-Rey, Iria
    Jara, Lorena
    Almela, Pedro
    Codesido, Laura
    de la Maza, Saioa
    Leal, Carles
    Caballol, Berta
    Perez-Martinez, Isabel
    Vinuesa Campo, Raquel
    Crespo, Javier
    Domenech, Eugeni
    Chaparro, Maria
    Gisbert, Javier P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 65 - 74
  • [39] Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn's disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry
    Biemans, V.
    van der Woude, J.
    Dijkstra, G.
    van der Meulen-de Jong, A.
    Lowenberg, M.
    de Boer, N.
    Oldenburg, B.
    Srivastava, N.
    Jansen, J.
    Bodelier, A.
    West, R.
    de Vries, A.
    Haans, J.
    de Jong, D.
    Hoentjen, F.
    Pierik, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S114 - S116
  • [40] Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
    Biemans, Vince B. C.
    van der Woude, C. Janneke
    Dijkstra, Gerard
    van der Meulen-de Jong, Andrea E.
    Lowenberg, Mark
    de Boer, Nanne K.
    Oldenburg, Bas
    Srivastava, Nidhi
    Jansen, Jeroen M.
    Bodelier, Alexander G. L.
    West, Rachel L.
    de Vries, Annemarie C.
    Haans, Jeoffrey J. L.
    de Jong, Dirk
    Hoentjen, Frank
    Pierik, Marieke J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 123 - 134
12345